Joint Formulary & PAD

Brimonidine tartrate - Rosacea

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Non Formulary
Formulations :
  • Gel
Associated Icons :
SPC
Restrictions / Comments :

PAD Profile

ChemicalSubstance :
Brimonidine tartrate
Indication :
Rosacea
Group Name :
Keywords :
facial erythema
Brand Names Include :
Mirvaso
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
2

Other Indications

Below are listed other indications that Brimonidine tartrate is used to treat.

Other Drugs

Below are listed other drugs that are used to treat Rosacea.

Committee Recommendations (1)

The PCN does not routinely support the use of Brimonidine for facial erythema of Rosacea in primary Care and this should be considered as BLACK on the traffic light system.